Andrej Sali

Corporate Officer/Principal at The University of California, San Francisco

Consumer Services

Health Technology

Profile

Dr. Andrej Sali is Co-Founder at Global Blood Therapeutics, Inc. and a Professor at The University of California, San Francisco.
Dr. Sali was previously employed as an Associate Professor by The Rockefeller University and Founder by Prospect Genomix, Inc. He received his undergraduate degree from the University of Ljubljana and a doctorate degree from the Birkbeck University of London.

Andrej Sali active positions

Companies	Position	Start
The University of California, San Francisco	Corporate Officer/Principal	-

All active positions of Andrej Sali

Former positions of Andrej Sali

Companies	Position	End
The Rockefeller University	Corporate Officer/Principal	-
Prospect Genomix, Inc.	Founder	-
GLOBAL BLOOD THERAPEUTICS, INC.	Founder	-

See the detail of Andrej Sali's experience

Training of Andrej Sali

University of Ljubljana	Undergraduate Degree
Birkbeck University of London	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrej Sali's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Global Blood Therapeutics, Inc. Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.	Health Technology
Prospect Genomix, Inc.